2025-12-15T12:14:44-06:00 2025-06-30 582676261 Rogers & Company PLLC 8300 Boone Boulevard Suite 600 Vienna VA 22182 990 2024-07-01 311726494 EcoHealth Alliance Inc ECOH 2123804460 6 Liberty Square PMB 520 Boston MA 02109 Joseph Riccardi CFO 2123804460 2025-12-12 1 1 Amanda E Waterhouse P02014004 7038930300 2025-12-12 2024 2025-03-06 01:10:19Z X Joseph Riccardi 6 Liberty Square PMB 520 Boston MA 02109 9479596 0 X www.ecohealthalliance.org X 2000 MA Protecting global health by preventing the outbreak of emerging diseases and safeguarding ecosystems by promoting conservation. 22 21 54 21 0 0 13609471 6811735 44271 14328 695341 1170009 68034 0 14417117 7996072 6218414 1321646 0 0 7820935 4256758 120766 0 214998 4685141 5031831 18845256 10610235 -4428139 -2614163 13947293 1690732 11139790 9139552 2807503 -7448820 X EcoHealth Alliance integrates innovative science-based solutions and partnerships that increase capacity to achieve two interrelated goals: protecting global health by preventing the outbreak of emerging diseases and safeguarding ecosystems by promoting conservation. 0 0 1412278 1172365 Conservation Works-Liberia: Liberia Conservation Works (CW) is designed to protect threatened and endangered species by strengthening protected and conserved areas while promoting economic growth in Liberia. CW supports communities in becoming less reliant on forest resources by providing livelihood alternatives, including sustainable agriculture and ecotourism. CW works closely with the Government of Liberia, private sector partners, and local conservation stakeholders and communities. 213135 111706 DTRA CCHF: The objective of this grant is to reduce the threat of Crimean-Congo hemorrhagic fever (CCHF) by determining the presence and scale of CCHF virus (CCHFV) circulation in Tanzania. The awardee shall establish a multi-disciplinary team of Tanzanian and international One Health professionals to collect fundamental data on CCHFV, conduct rigorous scientific analyses and support the Government of Tanzania in the development of policies to control and reduce the threat of CCHF. Using a One Health approach the awardee shall investigate the following three hypotheses: 1) CCHFV is circulating in ticks, livestock and wildlife in Tanzania; 2) CCHFV is present and circulating in the human population in Tanzania; 3) CCHFV prevalence, seroprevalence and vector abundance will vary across an environmental disturbance gradient from peri-urban communities, to pastoral rangelands, to protected wildlife areas. The awardee shall support the capacity of Tanzanian human and animal health laboratories to detect anti-CCHFV antibodies, train Tanzanian field researchers and provide vital data to Tanzanian government partners and stakeholders to develop policies to prepare for and reduce the threat of a CCHF outbreak. 152151 18866 DTRA RVFV- Reducing the Threat of Rift Valley Fever through Ecology, Epidemiology and Socio-Economics: The objective of this grant is to reduce the threat of RVF by improving the understanding of RVFV circulation during inter-epidemic periods, improving local capacity to predict periods of high risk for RVF outbreaks and determining the multi-sectoral cost of RVF in the Republic of South Africa (RSA). Studies in the Free State/Northern Cape (FS/NC) and KwaZulu-Natal (KZN) regions will generate new understanding of RVF maintenance, circulation and impacts and improve risk prediction models for the country. Through multi-disciplinary investigation of three core hypotheses, the project shall strengthen South Africa's leadership role within the African continent to reduce the threat of RVF and other vector-borne diseases through the characterization of RVFV epidemiology and ecology in tropical and temperate ecosystems. 113570 18710 DTRA Jordan: The objective of this grant is to reduce the threat of high-consequence zoonotic pathogens in Jordan and improve regional disease surveillance capacity. Jordan faces risk of several zoonoses of concern to human and animal health, including Middle East Respiratory Syndrome (MERS-CoV) and Avian Influenza (AI), with fundamental knowledge and capacity gaps around the distribution and determinants of zoonoses. Recent work by our team detected MERS-CoV in camels and people in Jordan, suggesting ongoing and unmitigated transmission risk of a priority pathogen. The study generates critical advances in determining the presence of zoonotic pathogens in the country and opportunities for public health intervention. Through a prospective human cohort study coordinated with animal sampling, we will conduct biological and behavioral surveillance in five regions of Jordan with livestock production interfaces to determine the presence and risk factors for MERS-CoV, AI, brucellosis, and leptospirosis to identify modifiable risk factors. 2316770 14328 Other miscellaneous programs 2430340 18710 14328 4207904 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 22 0 1 54 1 0 0 0 0 0 0 0 0 0 0 0 0 X 22 21 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AK AZ AR CA CO CT DC FL GA HI IL KS KY LA ME MD MA MI MN NH NJ NY NC OH OK OR PA RI SC TN UT VA WA WV AL X Joseph Riccardi 2123804460 6 Liberty Square PMB 520 Boston MA 02109 Peter Daszak President 45.00 X X 379239 0 79666 Stephen Shapiro Chair 20.00 X X 0 0 0 Ellen Shedlarz Vice-Chair 3.00 X X 0 0 0 Karen Denton Secretary 3.00 X X 0 0 0 Rick Baum Treasurer 3.00 X X 0 0 0 Juliet Agranoff Director 3.00 X 0 0 0 Amy Attas Director 3.00 X 0 0 0 Joe Curry Director 3.00 X 0 0 0 Rita Colwell Director 3.00 X 0 0 0 Jarret Stephens Director 3.00 X 0 0 0 Ralph Gormory Director 3.00 X 0 0 0 Charles Hirschler Director 3.00 X 0 0 0 Nancy Griffin Director 3.00 X 0 0 0 Bob Hoguet Director 3.00 X 0 0 0 Lilian Wu Director 3.00 X 0 0 0 David McIntyre Director 3.00 X 0 0 0 Geoffrey Potter Director 3.00 X 0 0 0 Lisa Silvershein Director 3.00 X 0 0 0 Pamela Thye Director 3.00 X 0 0 0 Nancye Green Director 3.00 X 0 0 0 Steven Wils Director 3.00 X 0 0 0 Carlota Vollhardt Director 3.00 X 0 0 0 Armine Arustamyan CFO (Until 08/16/24) 45.00 X 155769 0 35687 William Karesh Executive VP for Health and Policy 45.00 X 199504 0 42389 Jon Epstein VP for Science and Outreach 45.00 X 208200 0 60570 Kevin Olival VP for Research 45.00 X 205837 0 63043 Aleksei Chmura Chief of Staff 45.00 X 195865 0 49396 Joseph Riccardi CFO (Since 08/17/24) 45.00 X 136637 0 19011 Melinda Rostal Principal Scientist 45.00 X 166828 0 22752 Paula Prist Senior Research Scientist 45.00 X 118296 0 29533 Alison Andre Executive Assistant to the President 45.00 X 115210 0 22599 Kendra Phelps Program Manager and Senior Scientist 45.00 X 104519 0 45799 Catherine Machalaba Principal Scientist Health and Policy 45.00 X 104498 0 25726 2090402 0 496171 12 0 1 0 Arnold & Porter Kaye Scholer LLP 601 Massachusetts Ave NW Washington DC 200013743 Legal Services 785235 Tarter Krinsky & Drogin LLP 1350 Broadway New York City NY 10018 Legal Services 715541 Steptoe 1330 Connecticut Avenue NW Washington DC 20036 Legal Services 430178 3 4004626 2807109 15305 6811735 Publications 541700 14328 14328 14328 140698 140698 2512835 1483524 1029311 1029311 1029311 7996072 14328 0 1170009 483876 483876 837770 837770 1697409 1044100 653309 1592501 1002144 546541 43816 164768 164768 576484 19296 557188 225596 225596 2109952 2109952 20502 20502 698979 657007 35625 6347 1943 334 188 1421 77162 22199 46336 8627 156393 43235 100889 12269 354727 354727 84203 76412 7125 666 34083 15889 15146 3048 1865 1865 140647 140647 Bad Debt 1324823 1188176 136647 Field costs 5642 5642 20910 18753 2157 10610235 4207904 6187333 214998 476881 52213 4183366 49550 0 280502 590994 210993 0 0 250539 0 5050070 1097474 3395443 0 13947293 1690732 3662255 2236900 3877760 6902652 3599775 0 11139790 9139552 X 2505204 -7751119 302299 302299 2807503 -7448820 13947293 1690732 -2614163 -868366 -6773794 0 X X 0 0 0 X 11465094 14088934 17892523 13609471 6811393 63867415 11465094 14088934 17892523 13609471 6811393 63867415 63867415 79950 96296 108270 132559 140698 557773 48722 39270 48412 250510 386914 64812102 444196 0.98540 0.98360 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 Sub-Saharan Africa Grantmaking 194953 Europe (Including Iceland & Greenland) Grantmaking 642817 0 0 0 0 0 0 837770 0 837770 Sub-Saharan Africa Conservation 30055 Wire 0 Sub-Saharan Africa Conservation 36669 Wire 0 Sub-Saharan Africa Conservation 49964 Wire 0 Sub-Saharan Africa Conservation 9357 Wire 0 Sub-Saharan Africa Conservation 9614 Wire 0 Sub-Saharan Africa Conservation 12183 Wire 0 Sub-Saharan Africa Conservation 12183 Wire 0 Sub-Saharan Africa Conservation 23298 Wire 0 Europe (Including Iceland & Greenland) Conservation 392718 Wire 0 Europe (Including Iceland & Greenland) Conservation 40538 Wire 0 Europe (Including Iceland & Greenland) Conservation 209561 Wire 0 14 0 0 0 0 0 0 0 Part I, Line 2: Subgrants with foreign entities are prepared through the offices of Finance and SRO and signed by the Finance Director. These subgrants contain a scope of work and a detailed budget plan. Sub-recipients prepare and submit invoices to the Finance Director. The invoices are reviewed for appropriateness and compliance for allowable/unallowable expenses. Supporting documents may include copies of receipts or copies of the sub-recipient accounting records. These invoices are then reviewed by the grant accountant and traced to the general ledger to determine eligibility for payment. The grant accountant also reviews invoices for compliance to line item budgets as applicable. The Principal Investigator reviews and approves payment. Significant variances to budget are reviewed by Finance and Principal Investigators, and if determined necessary, reported to the prime funder in the form of a re-budget request. The Center's accounting system tracks revenues expenditures on a project or "award" basis. Part I, line 3: Foreign expenditures are directly tracked and accounted for on the accrual method of accounting. 1 Washington State University 240 French Administration Building PO BOX 641025 Pullman WA 99164 916001108 501(c)(3) 74038 0 Conservation and emerging diseases Partners in Animal Protection and Conservation 24130 Shooting Star Drive Golden CO 80401 821844609 501(c)(3) 286688 0 Conservation and emerging diseases Solimar International 3400 11th Street NW Suite 200 Washington DC 20010 113769103 123150 0 Conservation and emerging diseases 2 1 Part I, Line 2: Subcontract agreements are signed with recipients who are selected on expertise and capacity criteria consistent with the U.S Federal Uniform Guidance requirements. Expenditures and outcomes are monitored through site visits, written reports, expense documentation and other review mechanisms. X 0 0 0 0 0 0 0 1 0 Peter Daszak President 379239 0 0 0 0 0 35487 0 44179 0 458905 0 0 0 Kevin Olival VP for Research 205837 0 0 0 0 0 17440 0 45603 0 268880 0 0 0 Jon Epstein VP for Science and Outreach 208200 0 0 0 0 0 11465 0 49105 0 268770 0 0 0 Aleksei Chmura Chief of Staff 195865 0 0 0 0 0 16400 0 32996 0 245261 0 0 0 William Karesh Executive VP for Health and Policy 199504 0 0 0 0 0 25968 0 16421 0 241893 0 0 0 Armine Arustamyan CFO (Until 08/16/24) 155769 0 0 0 0 0 20564 0 15123 0 191456 0 0 0 Melinda Rostal Principal Scientist 93632 0 0 0 73196 0 10544 0 12208 0 189580 0 0 0 Joseph Riccardi CFO (Since 08/17/24) 136637 0 0 0 0 0 6358 0 12653 0 155648 0 0 0 Kendra Phelps Program Manager and Senior Scientist 77972 0 0 0 26547 0 8496 0 37303 0 150318 0 0 0 Part I, Line 7 The bonuses are non-fixed and are merit based. The Chair of the Board of Directors evaluates the President and recommends a bonus based on his performance. Other staff bonuses are recommended by their supervisors based on staff performances and are reviewed and approved by the personnel committee comprised of the President, Chief Financial Officer and Operational Director. .99J3 . M*4,89,S,1 Form 990, Part VI, Section B, line 11b EcoHealth Alliance distributes completed copies of form 990 to each board member for review prior to filing. Any questions or changes are discussed with the preparer. After satisfactory review, the return is subsequently filed. Form 990, Part VI, Section B, line 12c The conflict of interest policy is contained in the Organization bylaws. All financial transactions and contractual arrangements are monitored by the Chief Financial Officer who will prepare documentation for review by the Board as required by these policies. Any conflict of interest matter that involves staff members is brought to the attention of the president of EcoHealth Alliance. If it involves the President, the matter would be brought to the attention of the Chair of the Board. A matter that involves a member of the Board is brought to the attention of the Board or the Executive Committee in the absence of a Board meeting. Form 990, Part VI, Section B, line 15a The Board has established a sub-committee of the nominating and governance committee to review the compensation of the President. Performance reviews are done annually, including one done for FY 2024. Form 990, Part VI, Section C, line 19 EcoHealth Alliance will make all of these documents available to the public upon request. Form 990, Part XII, Line 3b: The organization did not undergo the audit under Uniform Guidance because it is anticipating dissolution. Wildlife Preservation TR International 520 Eight Avenue 1200 New York NY 10018 231996716 Wildlife Protection NY 501(c)(3) Line 7 EcoHealth 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0